'Lox on neovascularization': Leukotrienes as mediators in endothelial biology

Cardiovascular Research

Volumn 86, Issue 1, 2010, Pages 6-8

  Molin, Daniël G M ^a   Van Den Akker, Nynke M S ^a   Post, Mark J ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANGIOGENESIS; BIOLOGY; CELL DIFFERENTIATION; CELL MIGRATION; CHEMOTAXIS; EDITORIAL; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; HYDROLYSIS; INFLAMMATORY CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; ENDOTHELIUM, VASCULAR; HUMANS; LEUKOTRIENES; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION;

EID: 77949358366     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq054     Document Type: Editorial

References (12)

1. Poeckel D, Funk CD. The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease. Cardiovasc Res 2010; doi:10.1093/cvr/cvq016. Published online ahead of print 16 January 2010.
2. Finkensieper A, Kieser S, Bekhite MM, Richter M, Mueller JP, Graebner R et al. The 5-lipoxygenase pathway regulates vasculogenesis in differentiating mouse embryonic stem cells. Cardiovasc Res 2010;86:37-44.
3. Kim GY, Lee JW, Cho SH, Seo JM, Kim JH. Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogenesis. Arterioscler Thromb Vasc Biol 2009;29:915-920.
4. Nie D, Krishnamoorthy S, Jin R, Tang K, Chen Y, Qiao Y et al. Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells. J Biol Chem 2006;281:18601-18609.
5. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Freeman A, Showell HJ. Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler Thromb Vasc Biol 2002;22:443-449.
6. Haribabu B, Verghese MW, Steeber DA, Sellars DD, Bock CB, Snyderman R. Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. J Exp Med 2000; 192:433-438.
7. Hui Y, Cheng Y, Smalera I, Jian W, Goldhahn L, Fitzgerald GA et al. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure. Circulation 2004;110:3360-3366.
8. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25:2054-2061.
9. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003;100:4736-4741.
10. Gossl M, Herrmann J, Tang H, Versari D, Galili O, Mannheim D et al. Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia. Basic Res Cardiol 2009;104:695-706.
11. Yuan YM, Fang SH, Qian XD, Liu LY, Xu LH, Shi WZ et al. Leukotriene D4 stimulates the migration but not proliferation of endothelial cells mediated by the cysteinyl leukotriene cyslt(1) receptor via the extracellular signal-regulated kinase pathway. J Pharmacol Sci 2009;109:285-292.
12. Steiner DR, Gonzalez NC, Wood JG. Leukotriene B(4) promotes reactive oxidant generation and leukocyte adherence during acute hypoxia. J Appl Physiol 2001;91: 1160-1167.